Nigel A. Sharp
GlaxoSmithKline (United Kingdom)(GB)Age UK(GB)
Publications by Year
Research Areas
Viral-associated cancers and disorders, Immune Cell Function and Interaction, T-cell and Retrovirus Studies, Asthma and respiratory diseases, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammation(2008)372 cited
- → Translational control by the Epstein‐Barr virus small RNA EBER‐1(1990)84 cited
- → Mouse respiratory epithelial cells support efficient replication of human rhinovirus(2003)60 cited
- → Expression of genes for the Epstein--Barr virus small RNAs EBER-1 and EBER-2 in Daudi Burkitt's lymphoma cells: effects of interferon treatment(1992)33 cited
- → Expression and Purification of Recombinant, Glycosylated Human Interferon Alpha 2b in Murine Myeloma NSo Cells(1996)30 cited
- → Epstein-Barr virus gene expression in interferon-treated cells(1990)24 cited
- → Regulation ofin vitrotranslation by double-stranded RNA in mammalian cell mRNA preparations(1988)21 cited
- Regulation of c-fgr proto-oncogene expression in Burkitt's lymphoma cells: effect of interferon treatment and relationship to EBV status and c-myc mRNA levels.(1989)
- → Relative Transcriptional Inducibility of the Human Interferon-α Subtypes Conferred by the Virus-Responsive Enhancer Sequence(1996)16 cited
- → Epstein-Barr Virus Replication in Interferon-treated Cells(1989)12 cited